EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KAT2A Promotes the Progression of Renal Cell Carcinoma by Regulating the Succinylation of SERPINE2

Chang-Cheng Liu, Xue-Dong Li iD

The Kaohsiung Journal of Medical Sciences · 2026-11 · 42 (11)

DOI: 10.1002/kjm2.70211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, online erschienen am 12.04.2026. Verfasst von Chang-Cheng Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Serpin E2, Kidney Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial‐mesenchymal transition (EMT) and angiogenesis are critical drivers of renal cell carcinoma (RCC) progression, yet their upstream regulatory mechanisms remain incompletely understood. This study aimed to investigate the role of KAT2A in RCC and elucidate the underlying molecular mechanism by which it promotes tumor progression. To investigate KAT2A and SERPINE2 in RCC, we assessed their expression and downstream effects using real‐time quantitative PCR and western blot. EMT markers (E‐cadherin, N‐cadherin, Vimentin) and SERPINE2 succinylation were also measured. Functional assays (CCK‐8, colony formation, transwell, tube formation) evaluated cell viability, proliferation, migration, and angiogenesis. Co‐localization (immunofluorescence) and interaction (co‐immunoprecipitation) of KAT2A and SERPINE2 were confirmed. Finally, Ki‐67, KAT2A, and SERPINE2 expression in RCC tumors were examined via immunohistochemistry. We identified that KAT2A expression was significantly elevated in RCC tissues and correlated with poor patient prognosis. Functionally, KAT2A depletion markedly inhibited RCC cell proliferation, migration, EMT, and HUVECs angiogenesis in vitro, as well as suppressed tumor growth in vivo. Mechanistically, KAT2A directly interacted with SERPINE2 and promoted its succinylation at lysine 158 (K158). This post‐translational modification enhanced SERPINE2 protein stability, and SERPINE2 overexpression effectively reversed the tumor‐suppressive effects induced by KAT2A silencing. Our findings reveal that the KAT2A/SERPINE2 axis is a key regulator of RCC pathogenesis, identifying KAT2A‐mediated SERPINE2 succinylation as a novel mechanism and potential therapeutic target for RCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellSerpin E2Kidney NeoplasmsHumansEpithelial-Mesenchymal TransitionAnimalsCell ProliferationCell Line, TumorCell MovementMicep300-CBP-Associated FactorMaleGene Expression Regulation, NeoplasticDisease ProgressionFemaleMice, NudeNeovascularization, Pathologic

Stichwörter der Autor:innen

KAT2ASERPINE2Succinylationrenal cell carcinoma

Substanzen

Serpin E2SERPINE2 protein, humanp300-CBP-Associated Factor

Autor:innen und Institutionen

  • The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

ORCID-Profile: Xue-Dong Li

Zitieren

APA

Liu, C. C., & Li, X. D. (2026). KAT2A Promotes the Progression of Renal Cell Carcinoma by Regulating the Succinylation of SERPINE2. The Kaohsiung Journal of Medical Sciences, 42(11). https://doi.org/10.1002/kjm2.70211

Vancouver

Liu CC, Li XD. KAT2A Promotes the Progression of Renal Cell Carcinoma by Regulating the Succinylation of SERPINE2. The Kaohsiung Journal of Medical Sciences. 2026;42(11). doi:10.1002/kjm2.70211

BibTeX
@article{Liu2026,
  author = {Liu, Chang-Cheng and Li, Xue-Dong},
  title = {KAT2A Promotes the Progression of Renal Cell Carcinoma by Regulating the Succinylation of SERPINE2},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2026},
  volume = {42},
  number = {11},
  doi = {10.1002/kjm2.70211}
}
Kostenlos starten →